During the COVID-19 pandemic, on 27 March 2020, the Minister of Health commissioned the Agency to develop, in collaboration with the Expert Panel, the first version of the Recommendations in COVID-19. Due to advances in knowledge and new lessons learned during the pandemic, these Recommendations were updated in the areas of laboratory diagnostics (February 2022), clinical diagnostics (May 2021), and diagnostic imaging (May 2021).
A collection of updated Diagnostics recommendations in COVID-19:
*Ladies and Gentlemen
We inform you that the materials and results of the discussions posted on the Agency’s website are the result of the conceptual work and analytical process carried out by the team of the Agency for Health Technology Assessment and Tariff System based on the EBM paradigm, including: search, selection, synthesis and interpretation of scientific evidence, or the data analysis carried out .
In connection with the above, we would like to inform you that the use of analytical material or the results of the discussion, in accordance with good practice, should be accompanied by information on the source in the form: [title of presentation / report], AOTMiT, Warsaw, June 2021]